MAPT and Cognitive impairment: Since sevoflurane increased Tau phosphorylation and IL-6, and induced mitochondrial dysfunction, which then led to synaptic loss and cognitive impairment in the young mice, we could target Tau phosphorylation, IL-6 elevation, and mitochondria to prevent or treat the cognitive impairment in young mice.